Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Research|March 2, 2019
A Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant MelanomaTikvah K Hayes, Flora Luo, Ofir Cohen, et al.Nature Genetics|May 20, 2020
Cas9 activates the p53 pathway and selects for p53-inactivating mutationsOana M Enache, Veronica Rendo, Mai Abdusamad, et al.Nature Genetics|June 27, 2020
Author Correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutationsOana M Enache, Veronica Rendo, Mai Abdusamad, et al.Cell Reports|October 21, 2016
Phenotypic Characterization of a Comprehensive Set of MAPK1/ERK2 Missense MutantsLisa Brenan, Aleksandr Andreev, Ofir Cohen, et al.Nature Communications|December 22, 2019
Agreement between two large pan-cancer CRISPR-Cas9 gene dependency data setsJoshua M Dempster, Clare Pacini, Sasha Pantel, et al.Cancer Cell|December 12, 2018
Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer RemodelingAmanda Balboni Iniguez, Gabriela Alexe, Emily Jue Wang, et al.Cell|July 29, 2017
Defining a Cancer Dependency MapAviad Tsherniak, Francisca Vazquez, Phil G Montgomery, et al.Cancer Cell|August 2, 2016
High-throughput Phenotyping of Lung Cancer Somatic MutationsAlice H Berger, Angela N Brooks, Xiaoyun Wu, et al.Cancer Discovery|June 5, 2016
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 TargetingAndrew J Aguirre, Robin M Meyers, Barbara A Weir, et al.Molecular Cancer Research : MCR|August 30, 2019
Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian CancerElizabeth H Stover, Maria B Baco, Ofir Cohen, et al.Pageof 2